Ancora Advisors, LLC Novo Cure LTD Transaction History

Ancora Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $2,490 - $3,955	-44 Reduced 88.0%	6 $0
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $3,007 - $4,226	50 New	50 $7,000
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $6,520 - $11,279	-50 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $6,205 - $9,508	50 New	50 $7,000
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $8,580 - $11,161	-150 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $8,557 - $14,362	150 New	150 $10,000

290

75.6M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.13B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.